Pharmafile Logo
Pharmafocus logo
Advanced Search
huha-inc-ofvesgqrbjc-unsplash

Eli Lilly’s tirzepatide achieves 15.7% weight loss in adult patients

April 28, 2023
Research and Development

Eli Lilly has announced that tirzepatide (10mg and 15mg) achieved significant and superior weight loss compared to a placebo over …

News

First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study

April 27, 2023
Research and Development Avacta

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …

News
Press release

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

April 27, 2023
Business Services CHMP, Cosentyx, Dermatology, Novartis

Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …

News
Press release
markus-spiske-dnbtfbnqlrc-unsplash_1

GSK’s RSV vaccine candidate gains positive EMA CHMP opinion

April 27, 2023
Medical Communications

GSK has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has shared a …

News

FDA approves first orally-administered faecal microbiota product for preventing serious gut infection

April 27, 2023
Medical Communications

The US Food and Drug Administration (FDA) has announced that it has approved the first orally-ingested faecal microbiota product for …

News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

National Institutes of Health awards grant for gammaCore clinical trial for patients with opioid use disorders

April 27, 2023
Research and Development

Bioelectronic medicine and wellness company electroCore have announced that the National Institute on Drug Abuse (NIDA) part of the National …

News
anirudh-djo3injpaoe-unsplash_3

NICE recommends two CAR T treatments for blood cancers to the Cancer Drugs Fund

April 27, 2023
Medical Communications

The National Institute for Health and Care Excellence (NICE) has announced that it is recommending two personalised immunotherapy treatments to …

News

Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology

April 26, 2023
Business Services

Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, …

News
Press release

Epsilogen announces significant expansion of management team with three new senior hires

April 26, 2023
Business Services

London, 26 April 2023 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to …

News
Press release

Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes

April 26, 2023
Business Services

Burgess Hill, 26 April 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that real world data shows a …

News
Press release

FDA shares safety warning on amniotic fluid eyedrops

April 26, 2023
Medical Communications

The US Food and Drug Administration (FDA) has released a Public Safety Notification on eyedrops containing amniotic fluid currently being …

News
max-bender-w5bn80xghre-unsplash_1

FDA grants accelerated approval for QALSODY (tofersen) as ALS treatment

April 26, 2023
Medical Communications

Biogen has announced that the US Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100mg/15ml injection for the treatment …

News
national-cancer-institute-l8twzt4ccvq-unsplash_1

UCB and Huma Therapeutics collaborate on digital health solution to improve rare disease management

April 26, 2023
Medical Communications

Digital health company Huma Therapeutics and biopharmaceutical company UCB are partnering to offer a digital technology solution to aid patients …

News
jair-lazaro-0lrjo37r6nk-unsplash

Abbott announces two FDA clearances for life support system

April 26, 2023
Medical Communications

US-based medical devices and healthcare company Abbott has announced two new clearances from the US Food and Drug Administration (FDA) …

News

MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases

April 25, 2023
Business Services

London, United Kingdom, April 25, 2023 — MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target …

News
Press release

PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

April 25, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …

News
Press release

Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

April 25, 2023
Business Services

London, UK: Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a …

News
Press release

Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference

April 25, 2023
Business Services

Cambridge, UK, April 25, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to …

News
Press release
national-cancer-institute-kmvohcb-w5g-unsplash_1

EMA validates marketing authorisation application for Jemperli with chemotherapy

April 25, 2023
Medical Communications

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication …

News
testalize-me-0je8ynv4mis-unsplash

3B Pharmaceuticals and Novartis enter into licensing agreement for FAP-targeting technology

April 25, 2023
Research and Development

German biotechnology company 3B Pharmaceuticals (3BP) and Switzerland-based Novartis have announced that they have entered into a Global Exclusive Licensing …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026